The ATPase family, AAA domain-containing protein 2 (ATAD2) has a C-terminal bromodomain, which functions as a chromatin reader domain recognizing acetylated lysine on the histone tails within the nucleosome. ATAD2 is overexpressed in many cancers and its expression is correlated with poor patient outcomes, making it an attractive therapeutic target and potential biomarker. We solved the crystal structure of the ATAD2 bromodomain and found that it contains a disulfide bridge near the base of the acetyllysine binding pocket (Cys1057-Cys1079). Sitedirected mutagenesis revealed that removal of a free C-terminal cysteine (C1101) 
| INTRODUCTION
Eukaryotic DNA is packaged for gene regulation and nuclear organization into nucleosomal units consisting of approximately 146 base pairs of DNA wrapped around an octamer of histones. 1 Residues on the N-terminal tails protruding from the histone core are targeted by post-translational modifications, which contribute to gene regulation by supporting or inhibiting access to the genetic information. These heritable modifications are collectively called the "histone code," and they can propagate alternative phenotypes without any changes to the DNA sequence. 2, 3 Aberrant changes in the epigenome are linked to the development of disease, and have been shown to be one of the major mechanisms contributing to oncogenesis.
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The ε-N-lysine acetylation motif is one of the most common posttranslational modifications found in proteins. 7 Addition of an acetyl group neutralizes the positive charge on the lysine side-chain, and interrupts the interaction of histone proteins with the negativelycharged DNA, resulting in opening of the chromatin structure to increase gene expression. 7 Acetylation levels are tightly controlled by histone acetyl transferases (HATs; which create acetylation marks) and histone deacetylases (HDACs; which remove acetylation marks). 8 Histone acetylation is generally associated with euchromatin and gene active transcription, and these marks can also be important for DNA repair and replication. 9 Inappropriate histone acetylation has been linked to the abnormal expression of disease-promoting genes, particularly in cancer. 10 Bromodomains (BRDs) are well-characterized "reader" modules that recognize ε-N-acetylated lysines found on the histone tails through a conserved asparagine residue in their hydrophobic binding pocket. 11 Bromodomains are comprised of four α-helices (αZ, αA, αB, αC) that are connected by highly variable loop regions (ZA and BC loops), which form the rim of the histone binding pocket. 11 In addition, bromodomain structures frequently contain three stabilizing hydrophobic residues near the core of their helical bundle, as well as a tyrosine in the short αAZ helix, and an aspartate capping the αA helix, which forms a hydrogen bond with a backbone amide. 12 In the bromodomain and extra terminal domain (BET) subfamily of bromodomains a "WPF shelf" motif and a conserved gatekeeper residue were found to make hydrophobic contacts important for the selection of histone ligands 13 As an evolutionarily conserved domain, bromodomains function to guide the bromodomain-containing protein and any associated subunits to the chromatin. 14 Due to their presence in many transcriptional complexes, aberrant expression of bromodomain-containing proteins is increasingly recognized as a contributing factor in cancer cell proliferation and survival. 15 One such bromodomain-containing protein is the ATPase family, AAA domain-containing protein 2 (ATAD2, UniProtKB Q6PL18, also called ANCCA/PRO 2000). 16 ATAD2 has been shown to recognize histone H4 that is acetylated at lysine 5 (H4K5ac) and lysine 12 (H4K12ac), 17, 18 and has recently been proposed to function as a reader of newly synthesized H4K5acK12ac di-acetyllysine marks during DNA replication. 19 Several studies suggest a role for ATAD2 in the pathogenesis of cancer where it functions as a co-regulator of oncogenic transcription factors including E2F, 20, 21 the estrogen receptor-α, 16 the androgen receptor 22 , and MYC. 23, 24 Once initiated, ATAD2 expression leads to several positive feedback loops, dependent on tissue type, the products of which will further upregulate ATAD2, 16 cell proliferation, and survival genes. ATAD2 overexpression is associated with a myriad of unrelated cancers, including breast, 20, 23, [25] [26] [27] [28] colorectal, figure S1 ), and then transformed into E. coli One Shot BL21 Star (DE3;
Invitrogen) cells (ATAD2 CO). An ATAD2 bromodomain C1101A mutant protein was created using site-directed mutagenesis with the QuikChange II kit (Agilent). Primers were designed to introduce the C1101A mutation using standard PCR from the pDEST15 plasmid containing the codon optimized ATAD2 bromodomain as a template.
The ATAD2 C1057A, C1079A, and C1101A triple cysteine mutant was made in the same way from the codon-optimized plasmid. The DNA sequences for all mutants were verified before transformation into E. coli One Shot BL21 Star (DE3; Invitrogen) cells (ATAD2 CO C1101A and ATAD2 CO C1057A/C1079A/C1101A).
| ATAD2 bromodomain expression and purification
The wild-type and codon optimized mutant versions of the ATAD2 bromodomain protein were expressed from E. coli Rosetta 2 (DE3) pLysS or BL21 Star (DE3) cells grown in TB (Terrific Broth) at 37 C. Once the culture OD 600 reached 1.2, the temperature was reduced to 20 C for 1 hour before induction with 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG), and incubated for 16 hours at 20 C.
The cells were harvested by centrifugation and soniciated in lysis buffer containing 50 mM Tris pH 7.5, 500 mM NaCl, 0.05% Nonidet P-40, 5%
glycerol, and 1 mM EDTA. The ATAD2 bromodomain protein was purified using glutathione agarose resin (Thermo Scientific) in a 2.5 × 5 cm
BioRad econo-column with wash buffer (50 mM Tris pH 7.5, 500 mM NaCl, 5% glycerol and 1 mM EDTA). The GST tag was cleaved overnight at 4 C by addition of PreScission Protease (GE Healthcare), and the ATAD2 bromodomain was eluted with wash buffer, and the eluted fractions were pooled, concentrated and dialyzed into the appropriate buffers described below. The ATAD2 bromodomain total protein concentration was determined from its absorbance at 280 nm using the 
| X-ray crystallography
The WT ATAD2 bromodomain protein was purified using the lysis and wash buffers as described above that were supplemented with 1 mM dithiothreitol (DTT). Once the protein was eluted from the GST column it was concentrated and further purified by gel filtration chro- The diffraction data were processed using the Proteum3 suite (Bruker).
The structure was solved by molecular replacement using Phaser with the apo ATAD2B bromodomain structure (PDBID: 3DAI) as the starting model. 52 The model was built using COOT. 53 Notably, isomorphous difference maps did not support placement of the H2AK5ac peptide.
Instead, the anomalous difference map indicated a HEPES molecule from the crystallization buffer bound into the ATAD2 bromodomain binding pocket (Supporting Information figure S2 ). PHENIX and COOT were used for iterative rounds of refinement, density modification and model building. 53, 54 The final structure at 1.93 Å resolution was validated using MolProbity and Polygon.
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| Isothermal titration calorimetry
ITC measurements were performed using a MicroCal iTC200
(GE Healthcare) as described previously. 57 The WT and the mutant bro- All experiments where binding occurred were performed in triplicate,
while nonbinding experiments were performed in duplicate and standard errors are reported as standard deviations. HEPES and buffer ions were removed. We solvated the system in a cubic box with 85 Å side length and added K + and Cl − ions to neutralize the system and approximate an ionic strength of 150 mM. A short relaxation with molecular dynamics in torsional space 58 was run to reduce major clashes in the structure. The equilibration and production simulations were run with GROMACS 2016 59 using the CHARMM36 force field 60 with modified TIP3P water. 61 An equilibration of 1 ns in the NPT ensemble (constant number of molecules, pressure and temperature) at 1 bar and 310 K was run to let the box volume adapt to the correct density of the system. The average box side length of 84.04 Å calculated from this run was set for the following equilibration (0.5 ns) and production runs in the NVT ensemble (constant number of molecules, volume and temperature) at 310 K with velocity rescaling thermostat 62 with a coupling time of 2 ps. The electrostatic interactions were evaluated with the generalized reaction field 63 and we used a threshold of 12 Å for truncating all non-bonded interactions. All covalent bonds were constrained with LINCS 64 and the integration time was set to 2 fs. The two production simulations (with and without disulfide bridge) were run for 300 ns with saving frequency of 10 ps.
| Molecular dynamics simulations
3 | RESULTS AND DISCUSSION
| The ATAD2 bromodomain contains a disulfide bridge
We determined the crystal structure of the wild-type human ATAD2
bromodomain with a HEPES molecule from the crystallization buffer located in the acetyllysine-binding pocket (PDBID: 6CPS). The crystallographic data collection details and the refinement statistics are summarized in Table 1 . As expected, the ATAD2 bromodomain contains the canonical bromodomain protein-fold consisting of a left-handed four-helix bundle (αZ, αA, αB, and αC), with an extended C-terminal αC kinked helix ( Figure 1A ,B). The arrangement of the helical bundle creates a deep binding pocket that is surrounded by two variable loop regions that contribute to histone ligand binding specificity. Figure 1A , B shows the overall structure of the ATAD2 bromodomain from the front and back. Residues and structural features known to be important for coordination of H4K5ac 18 are labeled. These include the conserved asparagine N1064 that is responsible for co-ordinating the acetylated lysine group, Y1021, which coordinates an ordered water in the binding pocket, the RVF shelf motif (res 1007-1009, corresponding to the WPF shelf in BET bromodomains) and the gatekeeper residue I1074, both of which make important hydrophobic contacts with the histone ligand. Labeled in yellow are the positions of three cysteine residues in the ATAD2 bromodomain. There is one free Cterminal cysteine located after the kink in the extended αC helical formation of the disulfide bridge. As this is a unique structural feature of a bromodomain module we wanted to investigate if it has a role in histone ligand recognition, which could also potentially be important for current drug discovery efforts.
| Free sulfhydryl groups contribute to ATAD2 bromodomain aggregation in vitro
We used Ellman's reagent to estimate the number of free sulfhydryl groups available in the ATAD2 bromodomain samples by monitoring the formation of 2-nitro-5-thiobenzoic acid (TNB) by UV-Vis at 405 nm. 51 We estimated that the WT ATAD2 bromodomain protein expressed from Rosetta 2 cells has on average, 56% disulfide bridge formation ( Table 2) . As the crystal structure of the ATAD2 bromodomain also indicates that the disulfide bridge is partially formed, we concluded that when each of the three sulfhydryl groups is free, they are likely forming intermolecular disulfide bridges. Free thiol groups within protein structures are known to be highly reactive and can interact with other proteins in the solution creating intermolecular disulfide bridges linking two or more proteins together, or cause coordination are shown as sticks, and include the conserved Asn1064, which coordinates the acetyllysine, the gatekeeper residue Ile1074, Tyr1021 that coordinates ordered water in the binding pocket, and "RVF shelf" motif residues Arg1007, Val1008 and Phe1009, which are important for ligand selectivity. The residues forming the disulfide bridge include Cys1079 and Cys1057, and link the αB-αC helices near the base of the bromodomain binding pocket. The location of the C-terminal Cys1101 is also labeled. C, The 2Fo-Fc electron density map contoured at 1 σ around the ATAD2 bromodomain disulfide bridge region. D, The anomalous difference map contoured at 3 σ around the ATAD2 bromodomain disulfide bridge region. E, Structural alignment comparing ATAD2 proteins with and without an intact disulfide bridge. The apo structure of the ATAD2 bromodomain with no disulfide bridge (3DAI, orange) was taken from the Protein Data Bank and aligned to our ATAD2 structure with a 50% formed disulfide bridge (6CPS, slate) in PyMOL. 80 All figures were generated using PyMOL , and is a strategy that has been used to improve expression of other bromodomain-containing proteins. 74 In order to enhance the expression and co-translational folding of the WT human ATAD2 bromodomain protein in E. coli BL21 cell strains we developed a codon-optimized version of the ATAD2 bromodomain gene sequence (WT/CO ATAD2).
Codon-optimization of the ATAD2 bromodomain improved its expression, but did not improve overall solubility. Thus, we hypothesized that as the ATAD2 bromodomain proteins come in close contact with each other in solution, the availability of free sulfhydryl groups at positions C1057 and C1079 and C1101 allow for the formation of disulfide bridges between adjacent ATAD2 bromodomains causing them to aggregate. We believe this phenomenon makes it difficult to obtain a highly concentrated solution of the ATAD2 bromodomain protein in vitro, as we are only routinely able to reach concentrations slightly between 0.5 and 0.6 mM with the WT ATAD2 bromodomain, even in the presence of reducing agents such as DTT or TCEP. To circumvent aggregation we designed a C1101A mutant of the codon optimized ATAD2 bromodomain construct (ATAD2 CO C1101A) and tested its histone binding activity after expression in BL21 Star (DE3) cells. The ATAD2 bromodomain has been reported to bind to histone H4 that is acetylated at lysine 5 (H4K5ac). 17 As seen in Table 3 , and Supporting Information figure S3A the purified WT ATAD2 bromodomain protein with 56% bridge formation binds to histone H4K5ac
(residues 1-10) with a dissociation constant of 91.4 AE 6.1 μM using ITC. Comparably, the ATAD2 CO C1101A mutant bromodomain protein has 49% disulfide bridge formation, and ITC titrations TABLE 2 Expression and solubility of ATAD2 bromodomain proteins. The ATAD2 bromodomain protein from the native wild-type ATAD2 gene sequence (ATAD2 WT), the codon optimized ATAD2 C1101A mutant gene sequence (ATAD2 CO C1101A), and the codon optimized ATAD2 triple cysteine mutant (ATAD2 CO C1057A/C1079A/C1101A) were expressed and purified from E. coli host cell strains to optimize the protein production and solubility. 
| Disulfide bridge formation impacts ligand binding affinity
The two cysteine residues that form a disulfide bridge in the ATAD2 bromodomain are located near the base of the bromodomain binding pocket, opposite from the RVF shelf motif. Disulfide bridges play many important roles in protein structure. Formation of disulfide bonds is known to increase protein rigidity, thermal stability and contribute to folding of protein modules. 75 We postulated that disulfide bridge formation could contribute to the overall conformation of the bromodomain acetyllysine binding pocket, and play a role in the recognition of histone ligands.
As free sulfhydryl groups also negatively impact the ATAD2 bromodomain stability in solution we aimed to develop a method to isolate the ATAD2 bromodomain protein with 100% of the disulfide bridges formed. To do this, we expressed the ATAD2 CO C1101A mutant bromodomain protein in BL21 Star (DE3) cells, and added an additional purification step after elution from the glutathione agarose column. By applying the ATAD2 CO C1101A protein to an activated agarose 4B column that binds to any solutes containing free thiol groups, we were able to recover the fraction of the ATAD2 CO C1101A bromodomain sample that contains a fully formed disulfide bridge in the eluted protein. This protein was then further purified by size exclusion chromatography to desalt the sample prior to ITC experiments to test its histone-binding activity. The Ellman's assay confirmed we were able to isolate the ATAD2 CO C1101A bromodomain with a 100% formed disulfide bridge (Table 2) . Also, removal of any free cysteines improved the protein solubility significantly as we were able to concentrate it up to 1.9 mM without any signs of precipitation. Interestingly, the presence of the fully formed disulfide bridge reduces the binding affinity of the ATAD2 CO C1101A bromodomain for histone H4K5ac to 209.6 AE 21.0 μM, from the 96.5 AE 2.1 μM affinity observed with the ATAD2 CO C1101A bromodomain containing a 49% formed disulfide bridge (Table 3 and Supporting Information figure 3C-D) . Similarly, when we tested the binding affinity of Com- contains two disulfide bridges that are essential for the formation of STAT3 dimers that can shuttle into the nucleus and interact with DNA. Mutation of the four cysteine residues needed for the formation of intermolecular disulfide bridges in dimerization completely abolishes the DNA-binding activity of STAT3. 76 Expression of the ATAD2 protein is tightly regulated, and it is predominantly found in the nucleus during S phase where it is associated with DNA replication sites. 19 To investigate how complete removal of the disulfide bridge from the ATAD2 binding pocket would affect ligand binding we generated a triple cysteine mutant with residues C1057, C1079, and C1101 changed to alanine (ATAD2 CO C1057A/C1079A/C1101A).
As seen in Table 3 Two different RMSD metrics were employed; the slate and orange colors represent the RMSD of all Cα except three terminal residues (122 atoms in total) after alignment on the same set. The magenta and dark yellow colors encode the RMSD of the Cα of C1057, C1079 and two residues up-and downstream of them (10 atoms in total) after alignment on the four α-helices forming the bromodomain bundle. For each case all data points (dots) and a moving average (with a window of 100 data points) are reported. B, Root mean square fluctuations of the Cα atoms as a function of residue for the trajectory interval between 100 and 300 ns, averaged over stretches of 2 ns. The RMSF values were calculated by first aligning the trajectory to the crystal structure by using all Cα atoms. Then, we divided the trajectory into intervals of 2 ns and calculated the average structure for each interval. Finally, for each interval and residue we calculated the standard deviation (SD) of the coordinates of the Cα atom. The solid lines are the average over all the 100 intervals and the shaded envelope is at one SD distance. The calculation was carried out separately for the run with (slate) and without (orange) disulfide bridge. The vertical dashed lines mark the position of C1057 and C1079. A structural annotation of helical and loop (ZA and BC) regions is added at the bottom of the plot RMSF values around 0.5 Å for all but the C-terminal helix. The highest fluctuations are observed for the ZA loop in agreement with previous simulation studies. 79 Differences in binding affinity could also originate from different rotameric states of the residues in the binding site. Thus, we investigated two residues in the ATAD2 bromodomain binding site that are involved in hydrophobic interactions with natural and synthetic ligands. The statistical weights of the rotameric states of the gatekeeper residue I1074 and "RVF" shelf residue V1008 are not affected by the presence of the disulfide bridge (Supporting Information figure   S5 ). Overall, the very similar behavior observed in the molecular dynamics simulations with and without disulfide bridge is consistent with the relatively small difference in binding affinity as measured by ITC (less than 1 kcal/mol). found to have Cys residues in both the αB and αC helices. For example, the GCN5 bromodomain has a Cys residue in helices αB and αC.
In the X-ray crystal structure of the GCN5 bromodomain these two Cys residues are in close enough proximity to form a disulfide bridge, but a reduced state with no bridge formed is observed (PDBID: 3D7C). In the structures of the PCAF and BPTF bromodomains (PDBID: 3GG3 and 3UV2), the two cysteine residues are not positioned in the correct geometry to form a disulfide bridge, but with modest conformational changes to the side chains of these residues it may be possible for bridge formation to occur. The subfamily I bromodomain in the CECR2 protein, also contains two cysteine residues, but they are located too far apart from each other in the αB and αC helices to be able to form a disulfide bridge (PDBID: 3NXB). The only other two bromodomain proteins that contain a Cys residue in each of the αB and αC helices include the TRIM66 bromodomain in subfamily V, and the PRKCBP1 bromodomain in subfamily VII. The structure of the TRIM66 bromodomain has not been solved, but there is a structure available for the human PRKCBP1 bromodomain as a PHD-Bromo-PWWP cassette (PDBID: 4COS). However, in this structure the Cys residues in the αB and αC helices are on distal ends of the helices, and are not positioned close enough to form a disulfide bridge. Thus, formation of a disulfide bridge appears to be a unique structural feature of the ATAD2 and ATAD2B bromodomains, but it may also form in the GCN5, PCAF, and BPTF subfamily I bromodomains within the human bromodomain-containing proteins.
In summary, formation of a disulfide bridge near the ATAD2 binding pocket is a unique structural feature of this bromodomain that should be taken into consideration when examining ligand binding affinity, or in drug discovery efforts to develop new therapeutic compounds that interact with this module.
